Metformin × glycemic control

TrialPloS one2014

Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

Antonella Napolitano et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2014

No range given

Reported lower glycemic control, no range given

−21.0percentage points

As reported

difference −21.0 %, no interval

+1 more in the walkthrough ↓

Two numbers in the abstract

the abstract, start to end

concentrations were decreased by ∼21% (p<0.0001) from Visit 3 to

plasma glucose levels increased by ∼15% (p = 0.0006) from baseline to

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
−21.0
Adverse events & safety
15
MetforminGlycemic controlAdverse events & safety
1 / 4

151 papers cite itlatest 60 shown

2014
2016
2017
2018
2019
2020
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 24988476